Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Respir Physiol Neurobiol ; 162(3): 190-6, 2008 Aug 31.
Article in English | MEDLINE | ID: mdl-18611450

ABSTRACT

This study aimed to determine whether the route of administration of methacholine (MCh) influenced the pattern of airway hyper-responsiveness (AHR) in mice. BALB/c mice were inoculated with a 50-microL volume containing 10(4.5)-pfu Influenza virus A/Mem/1/71(H3N1) or media. MCh responsiveness in vivo [inhaled (0.01-30 mg/mL), i.v. MCh (6-48 microg/min/kg)] and in vitro were measured at day 4 post-infection (D4) during acute lower respiratory infection (LRI) and following resolution of infection at day 20 (D20) using a low-frequency, forced oscillation technique. Inflammation was assessed in bronchoalveolar lavage fluid. Infected mice had pulmonary inflammation and heightened responsiveness to both inhaled (p<0.03) and intravenous (p<0.02) MCh on D4, but not on D20. In vitro responsiveness was not altered at either time point. Influenza A LRI results in AHR during acute infection associated with a marked inflammatory response and increased permeability of the alveolar-capillary barrier. These data suggest that intrinsic muscle properties are not altered but MCh has greater access to airway smooth muscle during acute infection.


Subject(s)
Bronchial Hyperreactivity/etiology , Influenza A virus , Orthomyxoviridae Infections/complications , Respiratory Hypersensitivity/etiology , Analysis of Variance , Animals , Bronchial Hyperreactivity/drug therapy , Bronchoconstrictor Agents/administration & dosage , Cell Count/methods , Cytokines/metabolism , Dinoprostone/metabolism , Disease Models, Animal , Dose-Response Relationship, Drug , Drug Administration Routes , Female , In Vitro Techniques , Influenza Vaccines/administration & dosage , Lung/virology , Methacholine Chloride/administration & dosage , Mice , Mice, Inbred BALB C , Respiratory Hypersensitivity/drug therapy , Time Factors , Vascular Endothelial Growth Factor A/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL